about
HLA Class Ia and Ib Polyreactive Anti-HLA-E IgG2a Monoclonal Antibodies (TFL-006 and TFL-007) Suppress Anti-HLA IgG Production by CD19+ B Cells and Proliferation of CD4+ T Cells While Upregulating TregsEpicatechins Purified from Green Tea (Camellia sinensis) Differentially Suppress Growth of Gender-Dependent Human Cancer Cell Lines.Anticancer therapeutic potential of soy isoflavone, genistein.Anti-HLA-E monoclonal antibodies reacting with HLA-la and lb alleles like IVIg as potential IVIg-immunomimetics: an evolving therapeutic concept.Differential growth suppression of human melanoma cells by tea (Camellia sinensis) epicatechins (ECG, EGC and EGCG).Suppression of allo-human leucocyte antigen (HLA) antibodies secreted by B memory cells in vitro: intravenous immunoglobulin (IVIg) versus a monoclonal anti-HLA-E IgG that mimics HLA-I reactivities of IVIg.Gastric cancer progression may involve a shift in HLA-E profile from an intact heterodimer to β2-microglobulin-free monomer.Gangliosides as antigens of human melanoma.Establishment of stable cell lines for personalized melanoma cell vaccine.Ganglioside signatures of primary and nodal metastatic melanoma cell lines from the same patient.Increased levels of gangliosides in the plasma and ascitic fluid of patients with advanced ovarian cancer.Immunogenicity of membrane-bound gangliosides in viable whole-cell vaccines.The Monospecificity of Novel Anti-HLA-E Monoclonal Antibodies Enables Reliable Immunodiagnosis, Immunomodulation of HLA-E, and Upregulation of CD8+ T Lymphocytes.The Humoral Theory of Transplantation.Ratio of IgG:IgM antibodies to sialyl Lewis(x) and GM3 correlates with tumor growth after immunization with melanoma-cell vaccine with different adjuvants in mice.Antibodies to HLA-E may account for the non-donor-specific anti-HLA class-Ia antibodies in renal and liver transplant recipients.Anti-HLA-E mAb 3D12 mimics MEM-E/02 in binding to HLA-B and HLA-C alleles: Web-tools validate the immunogenic epitopes of HLA-E recognized by the antibodies.Heart transplantation in the United States from 1998 to 2008.Interleukin-2 binds to ganglioside GD(1b).Therapeutic preparations of IVIg contain naturally occurring anti-HLA-E antibodies that react with HLA-Ia (HLA-A/-B/-Cw) alleles.The cystacanth of Moniliformis moniliformis (Bremser, 1811) and its relationship with the haemocytes of the intermediate host (Periplaneta americana).Crustacean defense strategies. I. Molecular weight dependent clearance of dyes in the mud crab Scylla serrata (Forskal) (Portunidae: Brachyura).Conformational Variants of the Individual HLA-I Antigens on Luminex Single Antigen Beads Used in Monitoring HLA Antibodies: Problems and Solutions.An agglutinin with unique specificity for N-glycolyl sialic acid residues of thyroglobulin in the hemolymph of a marine crab Scylla serrata (Forskal).The hemocytes of an lsopod Ligia exotica Roux.Cryosurgical ablation of liver tumors in colon cancer patients increases the serum total ganglioside level and then selectively augments antiganglioside IgMSignificance of the intraindividual variability of HLA IgG antibodies in renal disease patients observed with different beadsets monitored with two different secondary antibodies on a Luminex platformO-acetylsialic acid-specific lectin from the crab Cancer anntenariusCopper toxicity in the crab, Scylla serrata, copper levels in tissues and regulation after exposure to a copper-rich mediumGangliosides of human melanoma: altered expression in vivo and in vitroThe hemocytes of a scorpion Palamnaeus swammerdamiCrab lectins: receptor specificity and biomedical applicationsCrustacean defense strategies II. Recognition, clearance, accumulation and externalization of soluble foreign proteins by the mud-crab Scylla serrataQuantitation of the density of cell surface carbohydrate antigens on cancer cells with a sensitive cell-suspension ELISAAn improved method for the measurement of total lipid-bound sialic acids after cleavage of alpha 2,8 sialic acid linkage with Vibrio cholerae sialidase in the presence of cholic acid, SDS and Ca2+Haemolymph protein concentration of Scylla serrata : assessment of quantitative methods and intra-individual variabilityAttachment of monophosphoryl lipid A (MPL) to cells and liposomes augments antibody response to membrane-bound gangliosidesCellular cancer vaccine induces delayed-type hypersensitivity reaction and augments antibody response to tumor-associated carbohydrate antigens (sialyl Le(a), sialyl Le(x), GD3 and GM2) better than soluble lysate cancer vaccineGangliosides as targets for immunotherapy for pancreatic adenocarcinomaProlonged survival of patients receiving active immunotherapy with Canvaxin therapeutic polyvalent vaccine after complete resection of melanoma metastatic to regional lymph nodes
P50
Q33786811-4AF6A6CF-7875-4641-9595-D01136247EA4Q34667547-673E9302-9108-4775-BAB1-EFC6B3E0BD2BQ35975993-F1C860D8-5D49-4070-9827-9FF49A26CE57Q38237193-8AC28FB2-931E-4CF6-8983-1CF0B1351AA3Q38498201-BC062838-EE79-4B7C-A2B0-6FB13C35A5A4Q39017122-5EDD65E8-D10B-41C9-BB8E-27F88B5FF032Q39084368-E3698866-1EEB-4897-9A80-2A4A7C9883D2Q39473668-698313F7-98D6-4322-BBC1-8965C5D2318AQ39717389-D05A5B59-85A1-44E1-B1CD-7A6D96143402Q40019588-A710CA49-33F0-405B-A0C3-56B21FE72E4AQ40545055-BC3DEB6E-C7FE-42FB-BC05-5977FFCA7040Q41605409-29F9BEEB-8A0F-4068-AEF3-BCBB8EA3290DQ41657410-01E4D154-8E7D-413C-A087-0A6763A730CAQ42355825-3C2612BF-596F-4D18-87DD-C145A4E69CA2Q42545715-4518543C-D1FC-4F5C-832E-30F16DBE0D43Q42629765-2B6D3B26-02B0-4ABD-BAAC-C9CB685872D4Q43408286-0479AD47-9E3B-4C11-A1A8-5E679A3BE8FCQ43525546-4394F5AD-BDD9-4A46-8D08-A2B7033AA71AQ43591477-45BB1A79-883E-4DA7-B91A-88975374A2A9Q44373752-3EEDC4C8-E7F8-4F4E-8269-14220CFA4B1CQ44784990-87C07367-E552-4946-8A02-E4F43A4DEF3DQ47243957-95581739-A03C-4094-A43B-CC7B0E94AAB5Q51591791-E8F6FFC8-FADA-489A-BA80-079833C60E17Q53845754-91AD9107-0CCE-4AB2-BF5B-50BB90415EBFQ53866841-059252FD-972A-475B-84D7-4DB8A1B6DF98Q57105919-3D88629A-B946-4C85-AFB1-AB266FB44042Q57457633-49FDE67A-B3E1-4370-9CD0-1C5BE9EF332AQ69076383-7083EF86-EC21-4837-9938-2B9C4BEF119EQ69465174-39A1BE6A-3905-4ADD-A835-E7561CC7BF75Q69745608-C65D06E6-51FC-47BD-93D3-22DECBB54B4BQ70024199-5DE3C2B0-81B4-4B21-AE51-12987CC5487EQ70384511-393F32F7-FC71-459E-8E1E-C442CCDE6536Q70672596-FC217E30-E2FF-4CA3-B901-5F1A5499CC22Q71724707-370B6B7D-2CB6-4BEF-B165-FFA7A293770AQ72366229-3C32F0BF-26EF-4D02-BC66-901C4087EE8FQ72611120-B061E40D-821A-4A36-9161-ADEAE683A558Q72625259-6BACDFCA-7AB5-4E09-BC88-CFD04AABB0A9Q73206352-F02AD2FB-21FB-4488-8D53-8868577FC320Q73666501-FFBB5FA0-B2C5-4112-8E98-B1C58FFE27FCQ78341872-03991C6D-DA23-4F48-9C9F-E4FF927E2A1C
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Mepur H. Ravindranath
@ast
Mepur H. Ravindranath
@en
Mepur H. Ravindranath
@es
Mepur H. Ravindranath
@nl
Mepur H. Ravindranath
@sl
type
label
Mepur H. Ravindranath
@ast
Mepur H. Ravindranath
@en
Mepur H. Ravindranath
@es
Mepur H. Ravindranath
@nl
Mepur H. Ravindranath
@sl
prefLabel
Mepur H. Ravindranath
@ast
Mepur H. Ravindranath
@en
Mepur H. Ravindranath
@es
Mepur H. Ravindranath
@nl
Mepur H. Ravindranath
@sl
P106
P1153
7006300266
P31
P496
0000-0002-5731-4129